MATRADE is looking to create export opportunities for Malaysian medical devices and healthcare services in the Middle East and North Africa (MENA) region by spearheading the participation of Malaysian companies at Arab Health 2023, which will be held in Dubai, United Arab Emirates (UAE) from 30 January – 2 February marking its 19th year of participation in this iconic event.
The trade agency under the Ministry Of International Trade and Investment is organising the participation of ten Malaysian medical devices and pharmaceutical companies at Arab Health 2023, namely, KPJ Healthcare Berhad, UEM Edgenta Berhad, Ain Medicare Sdn Bhd, Xepa-Soul Pattinson (Malaysia) Sdn Bhd, Ming Medical Sdn Bhd, Muzamal Industries Sdn Bhd, Timo International Sdn Bhd, TPE Healthcare Sdn Bhd, TUD Sdn Bhd and Twin Catalyst Sdn Bhd. Various high-value products and services from Malaysia will be promoted to over 50,000 global visitors expected at the event including medical consumables, pharmaceuticals, healthcare, and wellness products and services.
According to the Director of Lifestyle and Life Sciences MATRADE, Razida Hanim Abdul Razak, the Arab Health exhibition is in its 48th edition this year and undoubtedly, its stature as the premier healthcare trade platform is very much undisputed for many exhibitors. To date, the Arab Health exhibition has moved beyond the regional perspective and now attracts global trade visitors that have marked the event in their annual calendar, she added.
“Overall, demand for healthcare-related products and services in MENA is expected to reach RM33.31 billion (USD7.92 billion) in 2025. Participation in renowned large-scale events such as Arab Health will help to boost Malaysia’s branding among buyers,” said Razida.
In 2022, the top-five export destinations for Malaysian medical devices in the MENA region were Saudi Arabia, UAE, Egypt, Qatar, and Morocco. Collectively, these markets contributed 77.32 percent of Malaysia’s exports of medical devices to the region. Exports of medical devices to MENA region during this period registered at RM316.1 million.
